|
|
Article: United States : Recombinant Data Corp. Implements Visionary Translational Research Solution for UMass Medical School.
- Article from:
- TendersInfo
- Article date:
- September 4, 2009
CopyrightCOPYRIGHT 2009 Al Bawaba (Middle East) Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: Mamta03
Recombinant Data Corp., a healthcare data warehousing and clinical intelligence solutions provider, today announced that it has implemented a translational research solution at the University of Massachusetts Medical School.
The project, known as the Massachusetts Integrated Clinical Academic Research Database (MICARD), includes i2b2, an open source technology funded by the National Institutes of Health (NIH). i2b2 provides an Institutional Review Board (IRB)-compliant environment for managing and analyzing clinical data for population-based research, genomic research, clinical trials, and the development of new interventions and ...